E596-0434 Screening compound: 1-{4-[4-(3-chlorophenyl)piperazino]-4-oxobutyl}-4-ethylthieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one

E596-0434 Screening compound: 1-{4-[4-(3-chlorophenyl)piperazino]-4-oxobutyl}-4-ethylthieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one
E596-0434 Screening compound: 1-{4-[4-(3-chlorophenyl)piperazino]-4-oxobutyl}-4-ethylthieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one alternative view

Chemical Structure Depiction of ChemDiv screening compound E596-0434
1-{4-[4-(3-chlorophenyl)piperazino]-4-oxobutyl}-4-ethylthieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E596-0434

Molecular Formula

C23H25ClN6O2S (C23 H25 ClN6 O2 S)

Compound Name

1-{4-[4-(3-chlorophenyl)piperazino]-4-oxobutyl}-4-ethylthieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one

IUPAC name

12-{4-[4-(3-chlorophenyl)piperazin-1-yl]-4-oxobutyl}-8-ethyl-5-thia-181011-tetraazatricyclo[7.3.0.0^{26}]dodeca-2(6)3911-tetraen-7-one

SMILES

CCN(c1nnc(CCCC(N(CC2)CCN2c2cccc(Cl)c2)=O)n1-c1c2scc1)C2=O

InChI

InChI=1S/C23H25ClN6O2S/c1-2-29-22(32)21-18(9-14-33-21)30-19(25-26-23(29)30)7-4-8-20(31)28-12-10-27(11-13-28)17-6-3-5-16(24)15-17/h3,5-6,9,14-15H,2,4,7-8,10-13H2,1H3

InChI Key

UZNOLMDZHNMHPX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14902221

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.01

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.903

Distribution Coefficient, logD

2.903

Water Solubility, LogSw

-3.41

Polar Surface Area

60.374

Acid Dissociation Constant (pKa)

23.66

Base Dissociation Constant (pKb)

2.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.10

E596-0434 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E596-0434 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E596-0434?
Check Price and Availability of E596-0434, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E596-0434 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E596-0434
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E596-0434
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E596-0434 available by request